Researchers find high-dose therapy for liver disease not effective

A national team of researchers led by scientists at Mayo Clinic has found that a common treatment for primary sclerosing cholangitis, a chronic liver disease, is not helpful for patients, according to a study published this month in the journal Hepatology.

Read the whole article on Physorg

More from Physorg